Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada

INTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.

Bibliografiset tiedot

Päätekijät:	Amir A Tahami Monfared, Amy K O’Sullivan, Coleman Rotstein, George Papadopoulos
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2012-01-01
Sarja:	Canadian Journal of Infectious Diseases and Medical Microbiology
Linkit:	http://dx.doi.org/10.1155/2012/583630
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!